Emergent BioSolutions and Rocketvax Announce Investment Agreement and Pursuit of a Strategic Relationship for Next-Generation Product Candidates
Torqur AG Presents Interim Phase 2 Clinical Trial Results at American Academy of Dermatology
Spotlight on Leadership: Dr. Vladimir Cmiljanovic in The CEO Magazine
your name
your email
organization name